Centralized Biometrics

Effective Vendor Oversight Strategy

Increase quality, improve efficiency and cost savings thanks to an outsourcing model that highlights data as an asset and keeps all data related activities with one specialized vendor. This model creates considerable costs savings through standardization and improved efficiency. This yields a streamlined approach to oversight as required by ICH E6 (R2), consistent data strategy and handling and faster integration to support regulatory filings.

Key Elements of Centralized Biometrics

Improved Efficiency

  • Re-use of existing CRF pages to save on database build and statistical programming costs
  • Creation of global libraries of CRF pages and programs/macros
  • Utilization of one set of technologies so CRAs and Investigational Site staff benefit from familiarity
  • Better integration of studies across all phases with common assessment methods and increased efficiciency at time of reporting or regulatory filing
  • Centralized portal for viewing study data that facilitates data exploration, deployment of data visualization, and reporting across studies
  • Central warehouse for all clinical trial data and biometrics documents

Considerable Cost Savings

  • Volume discounts for EDC licensing fees and centralized hosting
  • Potential for FSP approach to all studies, creating additional cost savings

Maximized Partnerships

  • Enhanced understanding of your organization, needs and structure
  • Stable teams built on mutual understanding of working practices and shared vision
  • Development of tailored strategies and processes to meet your needs and expectations

Why choose Alira Health?

The CROS NT and Alira Health biometrics team has provided expert statistical guidance for over 500 projects, including regulatory communication and submissions, study-based data management, biostatistics, and statistical programming. You will benefit from our:

  • Leadership with in-depth industry knowledge from our expert biostatistician with more than 20 years of experience
  • Dedicated, experienced in-house data specialists, with an average of over 10 years of industry experience
  • Tiered governance approach designed to mitigate risks, guarantee quality, and improve efficiency of project teams

Related News

Publications September 16, 2022
Considerations for Analyzing and Interpreting Data from Biometric Monitoring Technologies in Clinical Trials
The rise of technology in clinical research allows us to capture meaningful aspects of health in clinical study participants.
Biometrics Clinical eCOA
Publications September 7, 2022
The Promise and Reality of Decentralized and Hybrid Clinical Trials in Europe Today
To understand the challenges related to hybrid and decentralized trials and ways to overcome them, we spoke with Dr. Hervé Solatges, Product Management, Evidence, and Innovation (DCT(...)
Clinical Decentralized Clinical Trials Hybrid Clinical Trials
Publications September 5, 2022
Taking In-Licensed Biologics to Market: Challenges, Complexities, and Ways to Overcome Them
Taking a biologic through drug development to market is highly complex and filled with challenges. To understand these challenges, their implications and how to overcome them, we spoke(...)
Biologics Clinical Drug Development
Events August 10, 2022
We are pleased to announce that we will be sponsoring and attending DPHARM, a unique event focused on the latest innovations that modernize clinical trials.
Clinical Decentralized Clinical Trials DPHARM Patient Centric
Publications August 2, 2022
GMP Manufacturing and IND-Enabling Studies of a Recombinant Hyperimmune Globulin Targeting SARS-CoV-2
The last two years have brought forward tremendous advances in the development of prophylactic and therapeutic approaches for the treatment of SARS-CoV-2 infections.
Clinical CMC Vaccines
Multimedia May 19, 2022
Fireside Chat Replay: Latest Developments in Oncology Supportive Care
In this fireside chat, we sit down with two medical experts in oncology and discuss some of the fascinating developments that are happening in the oncology supportive care field.
Events May 19, 2022
DIA 2022 Global Annual Meeting
We are pleased to announce that we will be joining DIA 2022 Global Annual Meeting as exhibitors and delegates.
Biometrics Clinical Life Sciences Regulatory
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.